Abstract: Compounds of formula (I) wherein R1, R2, R3, and HET-1 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.
Type:
Application
Filed:
August 7, 2006
Publication date:
June 24, 2010
Applicant:
ASTRAZENECA UK LIMITED AB
Inventors:
Darren McKerrecher, Gordon Kurt Pike, James Michael Warning